Treatment of Psychosis in Parkinson’s DiseaseSafety Considerations

被引:0
|
作者
Hubert H. Fernandez
Martha E. Trieschmann
Joseph H. Friedman
机构
[1] Brown University School of Medicine,Department of Clinical Neurosciences
来源
Drug Safety | 2003年 / 26卷
关键词
Clozapine; Risperidone; Olanzapine; Quetiapine; Ziprasidone;
D O I
暂无
中图分类号
学科分类号
摘要
Psychosis only rarely occurs in patients with untreated Parkinson’s disease. Much more commonly, psychosis is induced by drug therapy for Parkinson’s disease and is the strongest known risk factor for nursing home placement. Delusions are less frequent than hallucinations, but are more concerning as they are often paranoid in nature. Treatment begins with a search for correctable infectious, toxic, and metabolic aetiologies. If symptoms persist, anti-Parkinson’s disease medications are slowly reduced. However, withdrawal of these drugs usually worsens parkinsonism and is often not tolerated. Certain atypical antipsychotics can be used to treat psychosis without compromising motor function.
引用
收藏
页码:643 / 659
页数:16
相关论文
共 50 条
  • [1] Treatment of psychosis in Parkinson's disease - Safety considerations
    Fernandez, HH
    Trieschmann, ME
    Friedman, JH
    DRUG SAFETY, 2003, 26 (09) : 643 - 659
  • [2] Treatment of Parkinson's Disease Psychosis
    Schleisman, Andrew
    Spangler, Mikayla
    Knezevich, Emily
    US PHARMACIST, 2016, 41 (11) : HS20 - HS26
  • [3] Treatment of Parkinson’s Disease Psychosis
    Borek L.L.
    Friedman J.H.
    Current Treatment Options in Psychiatry, 2019, 6 (4) : 412 - 421
  • [4] TREATMENT OF PSYCHOSIS IN PARKINSON'S DISEASE AND PARKINSON'S DISEASE DEMENTIA
    Ballard, Clive
    Mills, R.
    Williams, H.
    Corbett, A.
    Cummings, J.
    NEUROBIOLOGY OF AGING, 2014, 35 : S2 - S2
  • [5] Pimavanserin for the treatment of Parkinson's disease psychosis
    Friedman, Joseph H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1969 - 1975
  • [6] Treatment of Psychosis and Dementia in Parkinson's Disease
    Goldman, Jennifer G.
    Holden, Samantha
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (03)
  • [7] Pimavanserin for the treatment of Parkinson's disease psychosis
    Chendo, Ines
    Ferreira, Joaquim J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (15) : 2115 - 2124
  • [8] Treatment of Psychosis and Dementia in Parkinson’s Disease
    Jennifer G. Goldman
    Samantha Holden
    Current Treatment Options in Neurology, 2014, 16
  • [9] Cannabidiol for the treatment of psychosis in Parkinson's disease
    Zuardi, A. W.
    Crippa, J. A. S.
    Hallak, J. E. C.
    Pinto, J. P.
    Chagas, M. H. N.
    Rodrigues, G. G. R.
    Dursun, S. M.
    Tumas, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S417 - S418
  • [10] Cannabidiol for the treatment of psychosis in Parkinson's disease
    Zuardi, A. W.
    Crippa, J. A. S.
    Hallak, J. E. C.
    Pinto, J. P.
    Chagas, M. H. N.
    Rodrigues, G. G. R.
    Dursun, S. M.
    Tumas, V.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (08) : 979 - 983